Literature DB >> 21562748

The TrkB-positive dopaminergic neurons are less sensitive to MPTP insult in the substantia nigra of adult C57/BL mice.

Yin-Xiu Ding1, Yi Xia, Xi-Ying Jiao, Li Duan, Jun Yu, Xi Wang, Liang-Wei Chen.   

Abstract

Tyrosine kinase receptors TrkB and TrkC mediate neuroprotective effects of the brain-derived neurotrophic factor (BDNF) and neurotrophins in the dopaminergic nigro-striatal system, but it is obscure about their responses or expression changes in the injured substantia nigra under Parkinson's disease. In present study, immunofluorescence, Fluoro-Jade staining and laser scanning confocal microscopy were applied to investigate distribution and changes of TrkB and TrkC in the dopamine neurons of the substantia nigra by comparison of control and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model. It revealed that TrkB and TrkC-immunoreactivities were substantially localized in cytoplasm and cell membrane of the substantia nigra neurons of control adults. While neurons double-labeled with tyrosine hydroxylase (TH)/TrkB, or TH/TrkC were distributed in a large numbers in the substantia nigra of controls, they apparently went down at 36.2-65.7% of normal level, respectively following MPTP insult. In MPTP model, cell apoptosis or degeneration of nigral neurons were confirmed by caspase-3 and Fluoro-Jade staining. More interestingly, TH/TrkB-positive neurons survived more in cell numbers in comparison with that of TH/TrkC-positive ones in the MPTP model. This study has indicated that TrkB-containing dopamine neurons are less sensitive in the substantia nigra of MPTP mouse model, suggesting that specific organization of Trks may be involved in neuronal vulnerability to MPTP insult, and BDNF-TrkB signaling may play more important role in protecting dopamine neurons and exhibit therapeutic potential for Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21562748     DOI: 10.1007/s11064-011-0491-5

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  54 in total

1.  Localization of nerve growth factor, neurotrophin-3, and glial cell line-derived neurotrophic factor in nestin-expressing reactive astrocytes in the caudate-putamen of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated C57/Bl mice.

Authors:  Liang-Wei Chen; Jin-Ping Zhang; Daisy Kwok-Yan Shum; Ying-Shing Chan
Journal:  J Comp Neurol       Date:  2006-08-20       Impact factor: 3.215

2.  Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease.

Authors:  Rodrigo Somoza; Carlos Juri; Mauricio Baes; Ursula Wyneken; Francisco Javier Rubio
Journal:  Biol Blood Marrow Transplant       Date:  2010-06-10       Impact factor: 5.742

3.  Neurotrophin-based strategies for neuroprotection.

Authors:  Frank M Longo; Stephen M Massa
Journal:  J Alzheimers Dis       Date:  2004-12       Impact factor: 4.472

4.  Haploinsufficiency for trkB and trkC receptors induces cell loss and accumulation of alpha-synuclein in the substantia nigra.

Authors:  Oliver von Bohlen und Halbach; Liliana Minichiello; Klaus Unsicker
Journal:  FASEB J       Date:  2005-07-21       Impact factor: 5.191

Review 5.  Emerging restorative treatments for Parkinson's disease.

Authors:  Tomas Deierborg; Denis Soulet; Laurent Roybon; Vanessa Hall; Patrik Brundin
Journal:  Prog Neurobiol       Date:  2008-05-14       Impact factor: 11.685

6.  Expression of trkB and trkC mRNAs by adult midbrain dopamine neurons: a double-label in situ hybridization study.

Authors:  S Numan; K B Seroogy
Journal:  J Comp Neurol       Date:  1999-01-18       Impact factor: 3.215

Review 7.  TGF-beta in dopamine neuron development, maintenance and neuroprotection.

Authors:  Eleni Roussa; Oliver von Bohlen und Halbach; Kerstin Krieglstein
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

Review 8.  Rasagiline promotes regeneration of substantia nigra dopaminergic neurons in post-MPTP-induced Parkinsonism via activation of tyrosine kinase receptor signaling pathway.

Authors:  Silvia A Mandel; Yotam Sagi; Tamar Amit
Journal:  Neurochem Res       Date:  2007-08-16       Impact factor: 3.996

9.  Identification and kainic acid-induced up-regulation of low-affinity p75 neurotrophin receptor (p75NTR) in the nigral dopamine neurons of adult rats.

Authors:  Yan-Qin Wang; Gan-Lan Bian; Ya Bai; Rong Cao; Liang-Wei Chen
Journal:  Neurochem Int       Date:  2008-06-28       Impact factor: 3.921

10.  Nigrostriatal neurons in rat express the glial cell line-derived neurotrophic factor receptor subunit c-RET.

Authors:  Yan-Qin Wang; Gan-Lan Bian; Li-Chun Wei; Rong Cao; Yi-Feng Peng; Liang-Wei Chen
Journal:  Anat Rec (Hoboken)       Date:  2008-01       Impact factor: 2.064

View more
  11 in total

Review 1.  Challenges and promises in the development of neurotrophic factor-based therapies for Parkinson's disease.

Authors:  Tiago Martins Rodrigues; André Jerónimo-Santos; Tiago Fleming Outeiro; Ana Maria Sebastião; Maria José Diógenes
Journal:  Drugs Aging       Date:  2014-04       Impact factor: 3.923

2.  MPP+-Lesioned Mice: an Experimental Model of Motor, Emotional, Memory/Learning, and Striatal Neurochemical Dysfunctions.

Authors:  Mauricio P Cunha; Francis L Pazini; Vicente Lieberknecht; Josiane Budni; Ágatha Oliveira; Júlia M Rosa; Gianni Mancini; Leidiane Mazzardo; André R Colla; Marina C Leite; Adair R S Santos; Daniel F Martins; Andreza F de Bem; Carlos Alberto S Gonçalves; Marcelo Farina; Ana Lúcia S Rodrigues
Journal:  Mol Neurobiol       Date:  2016-10-08       Impact factor: 5.590

3.  Programmed Death-1 Deficiency Aggravates Motor Dysfunction in MPTP Model of Parkinson's Disease by Inducing Microglial Activation and Neuroinflammation in Mice.

Authors:  Ying-Ying Cheng; Bei-Yu Chen; Gan-Lan Bian; Yin-Xiu Ding; Liang-Wei Chen
Journal:  Mol Neurobiol       Date:  2022-02-10       Impact factor: 5.590

4.  Neurotensin-polyplex-mediated brain-derived neurotrophic factor gene delivery into nigral dopamine neurons prevents nigrostriatal degeneration in a rat model of early Parkinson's disease.

Authors:  Nancy G Hernandez-Chan; Michael J Bannon; Carlos E Orozco-Barrios; Lourdes Escobedo; Sergio Zamudio; Fidel De la Cruz; Jose L Gongora-Alfaro; Juan Armendáriz-Borunda; David Reyes-Corona; Armando J Espadas-Alvarez; Yazmin M Flores-Martínez; Jose Ayala-Davila; Maria E Hernandez-Gutierrez; Lenin Pavón; Refugio García-Villegas; Rasajna Nadella; Daniel Martinez-Fong
Journal:  J Biomed Sci       Date:  2015-07-22       Impact factor: 8.410

Review 5.  Integral Characterization of Defective BDNF/TrkB Signalling in Neurological and Psychiatric Disorders Leads the Way to New Therapies.

Authors:  Gonzalo S Tejeda; Margarita Díaz-Guerra
Journal:  Int J Mol Sci       Date:  2017-01-28       Impact factor: 5.923

6.  Exercise does not protect against MPTP-induced neurotoxicity in BDNF haploinsufficient mice.

Authors:  Kim M Gerecke; Yun Jiao; Viswajeeth Pagala; Richard J Smeyne
Journal:  PLoS One       Date:  2012-08-17       Impact factor: 3.240

Review 7.  Potential therapeutic effects of neurotrophins for acute and chronic neurological diseases.

Authors:  Junying Cai; Fuzhou Hua; Linhui Yuan; Wei Tang; Jun Lu; Shuchun Yu; Xifeng Wang; Yanhui Hu
Journal:  Biomed Res Int       Date:  2014-04-09       Impact factor: 3.411

Review 8.  Gene Therapy for Parkinson's Disease, An Update.

Authors:  Tobias M Axelsen; David P D Woldbye
Journal:  J Parkinsons Dis       Date:  2018       Impact factor: 5.568

Review 9.  Regulation of BDNF-TrkB Signaling and Potential Therapeutic Strategies for Parkinson's Disease.

Authors:  Wook Jin
Journal:  J Clin Med       Date:  2020-01-17       Impact factor: 4.241

Review 10.  The Role of NEDD4 E3 Ubiquitin-Protein Ligases in Parkinson's Disease.

Authors:  James A Conway; Grant Kinsman; Edgar R Kramer
Journal:  Genes (Basel)       Date:  2022-03-14       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.